(Q37083428)

18 August 2017

1 reference

title

Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs (English)

1 reference

18 August 2017

1

1 reference

18 August 2017

publication date

1 September 2008

1 reference

Medicinal Research Reviews

18 August 2017

published in

1 reference

18 August 2017

volume

28

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

773-796

1 reference

Glycogen synthase kinase-3--an overview of an over-achieving protein kinase

18 August 2017

cites work

1 reference

Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes

21 January 2018

1 reference

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats

21 January 2018

1 reference

Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease

21 January 2018

1 reference

Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology

21 January 2018

1 reference

Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.

21 January 2018

1 reference

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

21 January 2018

1 reference

Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.20119

1 reference

18 August 2017

1 reference